Mayer S, Fowler A, Brohman I, Fairbairn N, Boyd J, Kerr T, McNeil R Motivations to initiate injectable hydromorphone and diacetylmorphine treatment: a qualitative study of patient experiences in Vancouver, Canada Int J Drug Policy PubMed

Dong H, Hayashi K, Fairbairn N, Milloy MJ, DeBeck K, Wood E, Kerr T Long term pre-treatment opioid use trajectories in relation to opioid agonist therapy outcomes among people who use drugs in a Canadian setting Addict Behav PubMed

Brar R, Fairbairn N, Colizza K, Ryan A, Nolan S Hospital initiated injectable opioid agonist therapy for the treatment of severe opioid use disorder: a case series J Addict Med PubMed

Dong H, Hayashi K, Milloy MJ, DeBeck K, Singer J, Wong H, Wood E, Kerr T Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting Drug Alcohol Depend PubMed

Braithwaite V, Fairgrieve C, Nolan S Sustained-release oral hydromorphone for the treatment of opioid use disorder J Addict Med PubMed

McWilliams C, Bonnie K, Robinson S, Johnson C, Puyat JH, Klimas J Preliminary results of psychiatric inpatients referred to an addiction medicine consult service J Addict Med PubMed